Hershey Trust Company’s AbbVie ABBV Stock Holding History

Hershey Trust Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,569	Closed	-$139K	–	17
2017 Q3	$139K	Buy	+1,569	New	+$119K	﹤0.01%	10

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Hershey Trust Company's ABBV Position: Q4 2017 in Review

Hershey Trust Company sold out of AbbVie (ABBV) in Q4 2017, closing a stake of 1,569 shares — an estimated $139K sold.

Hershey Trust Company first reported a position in ABBV in Q3 2017 and held it in 1 quarter. The position peaked at $139K in Q3 2017. 2,001 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

Hershey Trust Company reported no remaining AbbVie position as of Q4 2017 after selling out during the quarter.
Hershey Trust Company sold 1,569 AbbVie shares in Q4 2017, an estimated $139K.
Hershey Trust Company first reported a position in AbbVie in Q3 2017 and held it in 1 quarter.
Hershey Trust Company's AbbVie position peaked at $139K in Q3 2017.
2,001 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Hershey Trust Company's 13F filing for Q4 2017, filed 23 Jan 2018.